316 related articles for article (PubMed ID: 8644291)
1. Role of indirect allorecognition in chronic rejection of human allografts.
Suciu-Foca N; Liu Z; Colovai AI; Tugulea S; Reed EF; Mancini D; Cohen DJ; Benvenisty AI; Benstein JA; Hardy MA; Schulman LL; Rose EA
Transplant Proc; 1996 Feb; 28(1):404-5. PubMed ID: 8644291
[No Abstract] [Full Text] [Related]
2. Expression of class II major histocompatibility complex antigens and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
Hasegawa S; Ockner DM; Patterson GA; Ritter JH; Cooper JD; Wick MR
Transplant Proc; 1995 Feb; 27(1):1290-2. PubMed ID: 7878886
[No Abstract] [Full Text] [Related]
3. Differential expression of T-cell receptor-V region determinants on infiltrating T cells in rejecting and nonrejecting human kidney, liver, and heart allografts.
Ibrahim S; Dawson DV; Elmohsen MA; Elsamannoudy FA; Sanfilippo F
Transplant Proc; 1993 Feb; 25(1 Pt 1):80-3. PubMed ID: 8438488
[No Abstract] [Full Text] [Related]
4. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
5. Distribution of TCR alpha beta+ and TCR gamma delta+ lymphocytes in bronchoalveolar lavage from human lung transplant recipients.
Whitehead BF; Stoehr C; Finkle C; Patterson G; Theodore J; Clayberger C; Starnes VA
Transplantation; 1993 Oct; 56(4):1031-4. PubMed ID: 8212186
[No Abstract] [Full Text] [Related]
6. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
7. Overcoming Chronic Rejection-Can it B?
Kwun J; Knechtle SJ
Transplantation; 2009 Oct; 88(8):955-61. PubMed ID: 19855237
[TBL] [Abstract][Full Text] [Related]
8. Infiltration pattern of rat heart allografts during rejection.
Westra AL; Romaniuk A; Ryffa T; Wildevuur CR; Nieuwenhuis P
Transplant Proc; 1987 Feb; 19(1 Pt 1):374. PubMed ID: 3274787
[No Abstract] [Full Text] [Related]
9. Allograft vascular disease: comparison of heart and other grafted organs.
Radio S; Wood S; Wilson J; Lin H; Winters G; McManus B
Transplant Proc; 1996 Feb; 28(1):496-9. PubMed ID: 8644326
[TBL] [Abstract][Full Text] [Related]
10. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction.
Bedi DS; Riella LV; Tullius SG; Chandraker A
Transplantation; 2010 Nov; 90(9):935-44. PubMed ID: 20703180
[TBL] [Abstract][Full Text] [Related]
11. A perspective on the Revised Working Formulation for the grading of lung allograft rejection.
Yousem S
Transplant Proc; 1996 Feb; 28(1):477-9. PubMed ID: 8644317
[No Abstract] [Full Text] [Related]
12. Late airway changes in rat lung allografts: chronic rejection is a causative factor.
Uyama T; Sakiyama S; Monden Y; Winter JB; Prop J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1169-71. PubMed ID: 8442075
[No Abstract] [Full Text] [Related]
13. Self-MHC restricted T cells specific for donor peptides infiltrate human grafts during rejection.
Colovai AI; Liu Z; Cinti P; Harris PE; Drusin RE; Mancini DM; Gargano F; Hardy MA; Cortesini R; Rose EA; Suciu-Foca N
Transplant Proc; 1997; 29(1-2):1509-10. PubMed ID: 9123402
[No Abstract] [Full Text] [Related]
14. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
[TBL] [Abstract][Full Text] [Related]
15. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
16. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
17. Indirect recognition of MHC class I allopeptides accelerates lung allograft rejection in miniature swine.
Shoji T; Wain JC; Houser SL; Benjamin LC; Johnston DR; Hoerbelt R; Hasse RS; Lee RS; Muniappan A; Guenther DA; Bravard MA; Ledgerwood LG; Sachs DH; Sayegh MH; Madsen JC; Allan JS
Am J Transplant; 2005 Jul; 5(7):1626-34. PubMed ID: 15943620
[TBL] [Abstract][Full Text] [Related]
18. The role of histoincompatibility in cardiac allograft vasculopathy.
Costanzo MR
J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
[No Abstract] [Full Text] [Related]
19. Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously.
Lowry RP; Takeuchi T; Cremisi H; Konieczny B; Someren A
Transplant Proc; 1993 Apr; 25(2):2103-5. PubMed ID: 8470286
[No Abstract] [Full Text] [Related]
20. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
